The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells. (Q38840809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Daniele Del Rio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Furio Brighenti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Donatella Callegari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Alessio Lodola

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Carmine Giorgio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Elisabetta Barocelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Iftiin Hassan-Mohamed

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Massimiliano Tognolini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

13 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

Molecular Nutrition and Food Research

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

2155-2167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

Flavan-3-ols, anthocyanins, and inflammation

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Interaction between phenolics and gut microbiota: role in human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Eph-ephrin bidirectional signaling in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Therapeutic targeting of EPH receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Therapeutic perspectives of Eph-ephrin system modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Eph receptors at synapses: implications in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Eph receptors and ephrins in cancer: bidirectional signalling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Perturbation of the EphA2-EphrinA1 system in human prostate cancer cells by colonic (poly)phenol catabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Bioavailability and catabolism of green tea flavan-3-ols in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Some quantitative uses of drug antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Integrated Modeling Program, Applied Chemical Theory (IMPACT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Getting it right: modeling of pH, solvent and "nearly" everything else in virtual screening of biological targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Procyanidin B2 catabolism by human fecal microflora: partial characterization of 'dimeric' intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Dietary intake of 337 polyphenols in French adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Methods for isolating, identifying, and quantifying anthocyanin metabolites in clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Catabolism of coffee chlorogenic acids by human colonic microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Eph receptors and ephrins: therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500470

21 January 2018

Identifiers

DOI

10.1002/MNFR.201500470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26307544%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference